Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy
Shan Xu(Houston Methodist), Martin Stuschke(Essen University Hospital)
Cited by 16
Related Papers
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
|Radiotherapy and Oncology|2020|227
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
|Journal of Nuclear Medicine|2022|68
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
|Nature Cancer|2025|48
Cranioencephalic functional lymphoid units in glioblastoma
|Nature Medicine|2024|41
Diagnostic Accuracy of<sup>68</sup>Ga-FAPI Versus<sup>18</sup>F-FDG PET in Patients with Various Malignancies
|Journal of Nuclear Medicine|2024|31